A Double-Masked, Randomized, Multi-Center Phase 2 Study to Evaluate the Efficacy and Safety of Lacripep™ in Subjects With Dry Eye Associated With Primary Sjögren's Syndrome
Phase of Trial: Phase I/II
Latest Information Update: 03 Nov 2018
At a glance
- Drugs Lacritin (Primary)
- Indications Dry eyes; Sjogren's syndrome
- Focus Therapeutic Use
- Sponsors TearSolutions
- 08 Aug 2018 Planned End Date changed from 30 Jun 2018 to 30 Jun 2019.
- 08 Aug 2018 Planned primary completion date changed from 30 Jun 2018 to 30 Jun 2019.
- 28 Jul 2017 New trial record